GHRP-6 in Cytoprotection and Tissue Repair GHRP-6's research literature extends significantly beyond GH release into tissue protection and repair : Stroke therapy: A Phase I/II clinical trial examined GHRP-6 combined with recombinant EGF for acute ischemic stroke one of the few GHS compounds to reach clinical trials for a non-endocrine indication (Berlanga-Acosta et al., 2024) Lung injury: GHRP-6 ameliorates acute lung injury and prevents its progression to interstitial fibrosis in preclinical models (GHRP-6 in lung injury, 2025) Organ failure prevention: GHRP-6 has been investigated for multiple organ failure prevention in critical illness (Berlanga-Acosta et al., 2006) Cardiac protection: The peptide protects against doxorubicin-induced cardiotoxicity through prosurvival pathway activation (GHRP-6 cardioprotection, 2024) These cytoprotective effects appear to involve GHSR-1a-mediated anti-inflammatory, anti-apoptotic, and antioxidant signaling potentially independent of GH release itself
10.1016/S0140-6736(04)16044-3 Lancet 108 RettbergJ
PMID 9849822)Tier 1 primary [2]Sigalos JT, Pastuszak AW (2018): The Safety and Efficacy of Growth Hormone Secretagogues (Sex Med Rev
This is a (10mg) blend each of CJC-1295 (No DAC) (5mg) and Ipamorelin (5mg).
This 29 amino acid peptide represents the bioactive portion of growth hormone releasing hormone, offering a physiological method to elevate growth hormone levels without directly injecting synthetic growth hormone
Ready to Find Out Which Peptide Fits Your Goals
